FDA approves higher-dose version of Wegovy shots

Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more weight and keep it off. The U.S. Food and Drug Administration approved a 7.2-milligram dose of Danish drugmaker Novo Nordisk’s semaglutide. Previously, the highest approved dose of the drug, taken as a weekly shot, was 2.4 milligrams. The new dose received accelerated review through the FDA’s ultra-fast drug review program. The approval was granted 54 days after the request for review was approved, the agency said in a statement. The new dosage will be avail...